According toThe National Cancer Institute, breast cancer is officially the most common key in of cancer there is.
And while these numbers are scary, they only get more concerning.
In addition, breast cancer often shows nosymptomsuntil it is too late.
But a new DNA-based vaccine may be the answer we’ve been searching for.
Recently, phase one of a human trial for a DNA-based vaccine was completed, showing promising results.
The vaccine creates an immune response to the HER2 protein, allowing the body to fight it.
In the study, the only reported side effects included flu-like symptoms and soreness at the injection, perAxios.
Researchers are currently looking for participants for phase 2 of the trial.
